[Pharmacology of hydrazinocarbonic acids, hydrazinopeptides and various hydrazine derivatives. IV. Anticonvulsive effects of aliphatic hydrazinocarbonic acids, peptides containing these heteroconstituents and of other hydrazine derivatives].
D000085:Acetates / Q000627:therapeutic use; D000613:Aminobutyrates / Q000378:metabolism; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D001831:Body Temperature / Q000187:drug effects; D004597:Electroshock; D006834:Hydrazines / Q000627:therapeutic use*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007538:Isoniazid; D008297:Male; D010455:Peptides / Q000627:therapeutic use*; D051381:Rats; D012007:Rectum; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D013331:Strychnine; D013882:Thiosemicarbazones; D013997:Time Factors
D000085:Acetates; D000613:Aminobutyrates; D000927:Anticonvulsants; D006834:Hydrazines; D010455:Peptides; D013882:Thiosemicarbazones; D013331:Strychnine; D007538:Isoniazid
Zur Pharmakologie von Hydrazinokarbonsäuren, Hydrazinopeptiden und anderen Hydrazinderivaten. IV. Antikonvulsive Effekte von aliphatischen Hydrazinokarbonsäuren, Peptiden mit diesen Heterobestandteilen und anderen Hydrazinderivaten.